# Western Development Commission

> Western Development Commission is a VC fund backing Health Care. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Ballaghaderreen, Ireland
- Total investments: 45
- Last investment: Apr 2025
- Lead investor: 18%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/western-development-commission/
- Website: http://www.wdc.ie

Western Development Commission (WDC) is a government institution that offers economic and social development services to Galway, Clare, Mayo, Roscommon, Donegal, Leitrim, and Sligo counties. It provides employment creation; population growth, employment patterns, education levels, and social exclusion analysis; and infrastructure developmentservices. Additionally, the commission offers telecommunication, public transport, and renewable energy sectors development services in rural areas. It also provides business development services in rural tourism, marine, technology, and organic agriculture sectors. WDC was founded in 1997 and is based in Ballaghaderreen, Ireland.

## Contacts

5 contacts available for Western Development Commission. Shizune tracks 4 team members at Western Development Commission. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/western-development-commission?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $702k–$3.9M |
| Venture - Series Unknown | $753k–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 14 | 31% |
| Medical Device | 14 | 31% |
| Biotechnology | 7 | 16% |
| Medical | 6 | 13% |
| Information Technology | 4 | 9% |

48 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 17 | 38% |
| Funding Round | 7 | 16% |
| Venture - Series Unknown | 7 | 16% |
| Series A | 6 | 13% |
| Grant | 1 | 2% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 32 | 71% |
| United States | 2 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Allan Mulrooney | Interim Chief Executive Officer | 2 | https://shizune.co/investors/profile/allan-mulrooney |
| Ian Brannigan | Head of Regional Development | 0 | https://shizune.co/investors/profile/ian-brannigan |
| Patricia Teatum | Head Of Corporate Services | 0 | https://shizune.co/investors/profile/patricia-teatum |
| Tomas Siochain | CEO | 0 | https://shizune.co/investors/profile/tomas-siochain |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Galway Biomedical | Galway Biomedical develops and manufactures medical devices. |  | Series A | Apr 23, 2025 |  |
| Ovagen | Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics. | $2.2M | Series A | Oct 29, 2024 |  |
| Ovagen | Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics. | $2.2M | Series A | Oct 29, 2024 |  |
| Peroptyx | Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts. | $1.1M | Seed | Jul 10, 2024 |  |
| CitySwift | CitySwift is a data-driven scheduling and planning technology for urban bus networks. The company uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors,ensuring on-time performance and increased passenger satisfaction.CitySwift was established on September 1, 2016 by Alan Farrelly and Brian O'Rourke in Galway, Ireland.CitySwift was established in 2016 and is operating in Galway, Ireland. | $7.6M | Venture - Series Unknown | Feb 01, 2024 |  |
| FeelTect | FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M |  | Dec 20, 2023 |  |
| FeelTect | FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M | Seed | Dec 20, 2023 |  |
| Amara Therapeutics | Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform. | $1.6M | Seed | May 08, 2023 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M |  | Mar 31, 2023 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M | Seed | Mar 31, 2023 |  |

10 of 45 investments shown.

## Co-investors
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 22 deals together
- [Irrus Investments](https://shizune.co/investors/profile/irrus-investments) — VC Fund, 12 deals together
- [HBAN](https://shizune.co/investors/profile/halo-business-angel-network) — VC Fund, 7 deals together
- [HBAN Medtech Syndicate](https://shizune.co/investors/profile/hban-medtech-syndicate) — VC Fund, 7 deals together
- [Boole Investment Syndicate](https://shizune.co/investors/profile/boole-investment-syndicate) — VC Fund, 6 deals together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [All Investors in Ireland](https://shizune.co/investors/investors-ireland)
- [All VC Funds in Ireland](https://shizune.co/investors/vc-funds-ireland)
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [Health Care VC Funds in Ireland](https://shizune.co/investors/health-care-vc-funds-ireland)
- [Medical Device Investors](https://shizune.co/investors/medical-device-investors)
- [Medical Device VC Funds](https://shizune.co/investors/medical-device-vc-funds)

## FAQ

### What does Western Development Commission invest in?

Western Development Commission invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 45 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Western Development Commission's check size?

Western Development Commission typically joins rounds of $702k–$3.9M at Seed and $753k–$17M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Western Development Commission participates in.

### How do I contact Western Development Commission?

Public channels for Western Development Commission include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Western Development Commission?

The team at Western Development Commission includes Allan Mulrooney (Interim Chief Executive Officer), Ian Brannigan (Head of Regional Development) and Patricia Teatum (Head Of Corporate Services). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co